FHIR Release 3 (STU)

This page is part of the FHIR Specification (v3.0.2: STU 3). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3 R2

Practitioner-example-f006-rvdb

Patient Administration Work GroupMaturity Level: N/ABallot Status: InformativeCompartments: Practitioner

This is the narrative for the resource. See also the XML or JSON format. This example conforms to the profile Practitioner.

Generated Narrative with Details

id: f006

identifier: 937223645 (OFFICIAL), 134IDY41W988 (USUAL)

name: Rob van den Berk (OFFICIAL)

telecom: ph: 0205569288(WORK), R.A.vandenberk@bmc.nl(WORK), fax: 0205664987(WORK)

address: Galapagosweg 91 Den Burg 9105 PZ NLD (WORK)

gender: male

birthDate: 07/12/1975

 

Other examples that reference this example:

  • MedicationDispense/Oral Chemo
  • MedicationDispense/IV Antibiotic
  • MedicationDispense/SC Injection
  • MedicationDispense/PRN dose with condition
  • MedicationDispense/IV antibiotic
  • MedicationDispense/Tapering Dose
  • MedicationDispense/IV Chemo
  • MedicationDispense/Oral Chemo
  • MedicationDispense/Eye drops
  • MedicationDispense/Oral Drops
  • MedicationDispense/As Needed with condition
  • MedicationDispense/Suppository
  • MedicationDispense/OTC
  • MedicationDispense/KCL admixture
  • MedicationDispense/IV
  • MedicationDispense/Oral
  • MedicationDispense/Insulin
  • MedicationDispense/IV Chemo
  • MedicationDispense/Oral
  • MedicationDispense/Mutliple dosage lines
  • MedicationDispense/TPN Solution
  • MedicationDispense/As Needed with condition
  • MedicationDispense/Oral suspension
  • MedicationDispense/Topical Ointment
  • MedicationDispense/Patch
  • MedicationDispense/Antibiotic
  • MedicationDispense/Inhaler
  • MedicationDispense/Inhaler
  • MedicationDispense/Compound
  • MedicationDispense/Warfarin
  • MedicationDispense/Warfarin

    •  

    Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.